Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMDW) Assets (2023 - 2025)

Baird Medical Investment Holdings' quarterly Assets came in at $69.7 million in Q4 2025, down 10.6% year-on-year from $78.0 million in Q4 2024, and down 9.47% quarter-over-quarter from $77.0 million in Q2 2025.

Baird Medical Investment Holdings has reported Assets for 3 years, with the latest figure at $69.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Assets fell 10.6% year-over-year to $69.7 million; the trailing twelve-month figure through Dec 2025 stood at $69.7 million (down 10.6% YoY), and the FY2025 full-year result was $69.7 million, down 10.6% from the prior year.
  • Assets for Q4 2025 stood at $69.7 million, down from $77.0 million in the prior quarter.
  • The five-year high for Assets was $78.0 million in Q4 2024, with the low at $56.7 million in Q4 2023.
  • Average Assets over 3 years is $70.3 million, with a median of $73.3 million recorded in 2025.
  • Year-over-year, Assets jumped 37.48% in 2024 and retreated 10.6% in 2025.
  • Tracing BDMDW's Assets over 3 years: stood at $56.7 million in 2023, then surged by 37.48% to $78.0 million in 2024, then decreased by 10.6% to $69.7 million in 2025.
  • The last three Assets figures came in at $69.7 million (Q4 2025), $77.0 million (Q2 2025), and $78.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Baird Medical Investment Holdings - - - 69.70 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 69.70 Mn
Jun 30, 2025 76.99 Mn
Dec 31, 2024 77.96 Mn
Dec 31, 2023 56.71 Mn